US 10696710
Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway
granted A61KA61K2039/55511A61K2039/55561
Quick answer
US patent 10696710 (Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway) held by The Board of Regents of the University of Texas System expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/55511, A61K2039/55561, A61K31/7084, A61K39/39